前列腺癌骨转移多学科诊疗专家共识(2020版)

2020-07-30 中国抗癌协会泌尿肿瘤专业委员会 肿瘤防治研究.2020.47(7):479-486.

在欧美发达国家,前列腺癌居男性肿瘤发病率首位。现阶段我国前列腺癌的发病率及死亡率逐步升高,严重威胁着我国男性健康。由于我国前列腺癌筛查和早期诊断尚不普及,部分患者确诊时已经处于晚期阶段,而骨骼是前列腺

中文标题:

前列腺癌骨转移多学科诊疗专家共识(2020版)

发布日期:

2020-07-30

简要介绍:

在欧美发达国家,前列腺癌居男性肿瘤发病率首位。现阶段我国前列腺癌的发病率及死亡率逐步升高,严重威胁着我国男性健康。由于我国前列腺癌筛查和早期诊断尚不普及,部分患者确诊时已经处于晚期阶段,而骨骼是前列腺癌最主要的转移部位,因此对于此类骨转移患者,在积极治疗原发病灶的同时,如何预防和治疗骨转移及骨相关事件显得尤为重要。前列腺癌骨转移目前尚无统一的治疗方案,针对现阶段的诊疗状况,如何采取多学科综合治疗(multidisciplinary treatment, MDT)模式对肿瘤患者开展个体化治疗,进一步提高患者生活质量及延长患者生命,是制定本共识的目的。

相关资料下载:
[AttachmentFileName(sort=1, fileName=前列腺癌骨转移多学科诊疗专家共识_2020版_.pdf)] GetToolGuiderByIdResponse(projectId=1, id=faf8b1c0019615dc, title=前列腺癌骨转移多学科诊疗专家共识(2020版), enTitle=, guiderFrom=肿瘤防治研究.2020.47(7):479-486., authorId=0, author=, summary=在欧美发达国家,前列腺癌居男性肿瘤发病率首位。现阶段我国前列腺癌的发病率及死亡率逐步升高,严重威胁着我国男性健康。由于我国前列腺癌筛查和早期诊断尚不普及,部分患者确诊时已经处于晚期阶段,而骨骼是前列腺, cover=https://img.medsci.cn/2020831/1598886162846_2020535.jpg, journalId=0, articlesId=null, associationId=1440, associationName=中国抗癌协会泌尿肿瘤专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Jul 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>在欧美发达国家,前列腺癌居男性肿瘤发病率首位。现阶段我国前列腺癌的发病率及死亡率逐步升高,严重威胁着我国男性健康。由于我国前列腺癌筛查和早期诊断尚不普及,部分患者确诊时已经处于晚期阶段,而骨骼是前列腺癌最主要的转移部位,因此对于此类骨转移患者,在积极治疗原发病灶的同时,如何预防和治疗骨转移及骨相关事件显得尤为重要。前列腺癌骨转移目前尚无统一的治疗方案,针对现阶段的诊疗状况,如何采取多学科综合治疗(multidisciplinary treatment, MDT)模式对肿瘤患者开展个体化治疗,进一步提高患者生活质量及延长患者生命,是制定本共识的目的。</p> </div> </div> </div>, tagList=[TagDto(tagId=781, tagName=前列腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=781, guiderKeyword=前列腺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3451, appHits=268, showAppHits=0, pcHits=1054, showPcHits=3182, likes=1, shares=9, comments=22, approvalStatus=1, publishedTime=Mon Aug 31 23:21:54 CST 2020, publishedTimeString=2020-07-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Aug 31 23:02:50 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 15:41:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=前列腺癌骨转移多学科诊疗专家共识_2020版_.pdf)])
前列腺癌骨转移多学科诊疗专家共识_2020版_.pdf
下载请点击:
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1066886, encodeId=6bce106688620, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe765690927, createdName=柠檬一蚊一斤, createdTime=Thu Nov 04 11:42:34 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053037, encodeId=fd39105303ef3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b31b2509073, createdName=124b61f3m54(暂无昵称), createdTime=Sun Sep 19 16:29:52 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015630, encodeId=bf8a101563027, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/0a2513fcf13a40d0b7cefbf19efb116c/b9b7e818cc574d14a70c470375f4ccbd.jpg, createdBy=cc9f5598711, createdName=苏韵阑珊, createdTime=Wed Sep 08 11:21:14 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015629, encodeId=5dc6101562984, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/0a2513fcf13a40d0b7cefbf19efb116c/b9b7e818cc574d14a70c470375f4ccbd.jpg, createdBy=cc9f5598711, createdName=苏韵阑珊, createdTime=Wed Sep 08 11:21:01 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976198, encodeId=5e1b9e61983c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb6d1504369, createdName=wuhen96604, createdTime=Wed Jun 23 13:56:08 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-11-04 柠檬一蚊一斤

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1066886, encodeId=6bce106688620, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe765690927, createdName=柠檬一蚊一斤, createdTime=Thu Nov 04 11:42:34 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053037, encodeId=fd39105303ef3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b31b2509073, createdName=124b61f3m54(暂无昵称), createdTime=Sun Sep 19 16:29:52 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015630, encodeId=bf8a101563027, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/0a2513fcf13a40d0b7cefbf19efb116c/b9b7e818cc574d14a70c470375f4ccbd.jpg, createdBy=cc9f5598711, createdName=苏韵阑珊, createdTime=Wed Sep 08 11:21:14 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015629, encodeId=5dc6101562984, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/0a2513fcf13a40d0b7cefbf19efb116c/b9b7e818cc574d14a70c470375f4ccbd.jpg, createdBy=cc9f5598711, createdName=苏韵阑珊, createdTime=Wed Sep 08 11:21:01 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976198, encodeId=5e1b9e61983c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb6d1504369, createdName=wuhen96604, createdTime=Wed Jun 23 13:56:08 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-09-19 124b61f3m54(暂无昵称)

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1066886, encodeId=6bce106688620, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe765690927, createdName=柠檬一蚊一斤, createdTime=Thu Nov 04 11:42:34 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053037, encodeId=fd39105303ef3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b31b2509073, createdName=124b61f3m54(暂无昵称), createdTime=Sun Sep 19 16:29:52 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015630, encodeId=bf8a101563027, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/0a2513fcf13a40d0b7cefbf19efb116c/b9b7e818cc574d14a70c470375f4ccbd.jpg, createdBy=cc9f5598711, createdName=苏韵阑珊, createdTime=Wed Sep 08 11:21:14 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015629, encodeId=5dc6101562984, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/0a2513fcf13a40d0b7cefbf19efb116c/b9b7e818cc574d14a70c470375f4ccbd.jpg, createdBy=cc9f5598711, createdName=苏韵阑珊, createdTime=Wed Sep 08 11:21:01 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976198, encodeId=5e1b9e61983c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb6d1504369, createdName=wuhen96604, createdTime=Wed Jun 23 13:56:08 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-09-08 苏韵阑珊

    #肿瘤#加油

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1066886, encodeId=6bce106688620, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe765690927, createdName=柠檬一蚊一斤, createdTime=Thu Nov 04 11:42:34 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053037, encodeId=fd39105303ef3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b31b2509073, createdName=124b61f3m54(暂无昵称), createdTime=Sun Sep 19 16:29:52 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015630, encodeId=bf8a101563027, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/0a2513fcf13a40d0b7cefbf19efb116c/b9b7e818cc574d14a70c470375f4ccbd.jpg, createdBy=cc9f5598711, createdName=苏韵阑珊, createdTime=Wed Sep 08 11:21:14 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015629, encodeId=5dc6101562984, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/0a2513fcf13a40d0b7cefbf19efb116c/b9b7e818cc574d14a70c470375f4ccbd.jpg, createdBy=cc9f5598711, createdName=苏韵阑珊, createdTime=Wed Sep 08 11:21:01 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976198, encodeId=5e1b9e61983c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb6d1504369, createdName=wuhen96604, createdTime=Wed Jun 23 13:56:08 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-09-08 苏韵阑珊

    加油

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1066886, encodeId=6bce106688620, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe765690927, createdName=柠檬一蚊一斤, createdTime=Thu Nov 04 11:42:34 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053037, encodeId=fd39105303ef3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b31b2509073, createdName=124b61f3m54(暂无昵称), createdTime=Sun Sep 19 16:29:52 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015630, encodeId=bf8a101563027, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/0a2513fcf13a40d0b7cefbf19efb116c/b9b7e818cc574d14a70c470375f4ccbd.jpg, createdBy=cc9f5598711, createdName=苏韵阑珊, createdTime=Wed Sep 08 11:21:14 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015629, encodeId=5dc6101562984, content=加油, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210908/0a2513fcf13a40d0b7cefbf19efb116c/b9b7e818cc574d14a70c470375f4ccbd.jpg, createdBy=cc9f5598711, createdName=苏韵阑珊, createdTime=Wed Sep 08 11:21:01 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976198, encodeId=5e1b9e61983c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb6d1504369, createdName=wuhen96604, createdTime=Wed Jun 23 13:56:08 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-06-23 wuhen96604

    0

拓展阅读

2010 ACS 前列腺癌早期筛查指南

美国癌症学会(ACS,American Cancer Society) · 2010-03-01

2010CCO 前列腺癌根治性前列腺切除术病理T3或边缘阳性的辅助放射治疗

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2010-04-15

ESMO临床实践指南:前列腺癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-05-01

2008 前列腺癌骨转移临床诊疗专家共识(2008版)

恶性肿瘤骨转移及骨相关疾病临床诊疗专家组 · 2010-05-01

2011EAU前列腺癌诊疗指南

欧洲泌尿外科学会(EAU,European Association of Urology) · 2011-01-01

前列腺癌诊断标准

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-07-01